Stockreport

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial [Yahoo! Finance]

XORTX Therapeutics Inc.  (XRTX) 
PDF WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to provide a summary [Read more]